EPSRC-GSK Chair in Sustainable Chemistry
EPSRC-GSK Chair in Sustainable Chemistry
批准号:
EP/M005178/1
负责人:
Saul Tendler
金额:
$142.02万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We seek support from EPSRC strategic funds to secure the appointment of a high profile academic from overseas to establish a new Sustainable Processing of Chiral Molecular Materials research group at the University of Nottingham. The group will be a key part of the University's strategy and plans to establish a Centre of Excellence for Sustainable Chemistry in collaboration with the UK based pharmaceutical company GSK. The centre will build upon the University's existing strengths in Green Chemistry, multi-disciplinary links between Chemistry and Engineering, and strong links with industry to generate a critical mass of world-leading research capacity in the emerging discipline of Sustainable Chemistry. The new research group will be housed in a unique Carbon Neutral Laboratory (CNL) and will help address key global challenges within Society and Industry including lowering carbon footprint, optimising energy usage, reducing waste and conserving precious resources such as water and metals. This work will contribute towards several of EPSRC's challenge themes. The group will be led by Professor David Amabalino (currently at CSIC-Barcelona) and will explore novel sustainable processing routes to chiral molecular materials for use in energy and medicinal applications in a multi- and inter-disciplinary collaboration across Schools in the Faculty of Science, Engineering and Medicine and Health Sciences at Nottingham, and with leading academic collaborators.Funding is requested for 50% of the salary costs of the new appointee alongside key resources to establish and pump prime the research programme. This includes two 5 year postdoctoral fellowships together with consumables, equipment and associated costs.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.dyepig.2021.109836
发表时间:
2022-01
期刊:
Dyes and Pigments
影响因子:
4.5
作者:
[J. Humphreys;Ferdinando Malagreca;P. Hume;W. Lewis;E. Davies;S. Argent;D. Amabilino]
通讯作者:
J. Humphreys;Ferdinando Malagreca;P. Hume;W. Lewis;E. Davies;S. Argent;D. Amabilino
Correction: Controlling the preferential motion of chiral molecular walkers on a surface.
修正:控制表面上手性分子步行者的优先运动。
DOI:
10.1039/c9sc90124h
发表时间:
2019
期刊:
Chemical science
影响因子:
8.4
作者:
[Abbasi-Pérez D]
通讯作者:
Abbasi-Pérez D
DOI:
10.1021/jacs.5b11594
发表时间:
2016-05-11
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[Floris, Andrea, Haq, Sam, Kantorovich, Lev]
通讯作者:
Kantorovich, Lev
DOI:
10.3791/54193
发表时间:
2016-07-12
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Abrishamkar A, Paradinas M, Bailo E, Rodriguez-Trujillo R, Pfattner R, Rossi RM, Ocal C, deMello AJ, Amabilino DB, Puigmartí-Luis J]
通讯作者:
Puigmartí-Luis J
DOI:
10.1039/d1ce00039j
发表时间:
2021-02-28
期刊:
CRYSTENGCOMM
影响因子:
3.1
作者:
[Humphreys, Joshua, Pop, Flavia, Amabilino, David B.]
通讯作者:
Amabilino, David B.
The Midlands Ultracold Atom Research Centre
-
批准号:EP/E036473/1
-
项目类别:Research Grant
-
资助金额:$665.21万
-
财政年份:2008
-
负责人:Saul Tendler
-
依托单位:
LSI Doctoral Training Centres: University of Nottingham
-
批准号:EP/G500002/1
-
项目类别:Training Grant
-
资助金额:$99.44万
-
财政年份:2008
-
负责人:Saul Tendler
-
依托单位:
LSI Doctoral Training Centres: University of Nottingham
-
批准号:EP/F500092/1
-
项目类别:Training Grant
-
资助金额:$31.48万
-
财政年份:2007
-
负责人:Saul Tendler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
葛根有效成分甲氧异黄酮通过结合GSK3B抑制肺腺癌吉非替尼耐药的机制研究
-
批准号:2026JJ82166
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:艾正华
-
依托单位:
SMURF2 通过泛素化降解 GSK3B诱导上皮-间质转化促进口腔鳞癌转移的作用和机制研究
-
批准号:2026JJ82197
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢常军
-
依托单位:
PCSK9抑制剂通过GSK3/β-Catenin/SCD1轴调控皮脂腺细胞脂代谢治疗痤疮的机制研究
-
批准号:2026JJ82355
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:方曼
-
依托单位:
益生菌通过肠-脑轴调控PI3K/AKt/GSK-3β信号通路促进缺血性脑卒中神经功能修复的分子机制研究
-
批准号:2026JJ81949
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘超
-
依托单位:
Cdc42通过抑制GSK-3β激酶活性介导YAP/TAZ异常激活在骨关节炎滑膜纤维化中的作用机制研究
-
批准号:2026JJ81824
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴克
-
依托单位:
基于AKT/GSK-3信号通路探讨“调和营卫”法中药制剂对小儿功能性消化不良作用机制研究
-
批准号:JCZRLH202601544
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PTBP1通过GSK3β/Nrf2通路调控心肌细胞铁死亡参与心肌梗死机制研究
-
批准号:2026JJ81670
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐娟
-
依托单位:
基于GSK-3b Tyr216磷酸化修饰失活探讨Brazilin对癫痫的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:严洁萍
-
依托单位:
Trim37蛋白通过调控PTEN/AKT/GSK-3β/β-catenin信号通路影响肝细胞癌增殖、转移、耐药的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王清清
-
依托单位:
丙泊酚通过PI3K/Akt/GSK3β信号轴调控神经元自噬改善急性脑创伤的机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李晓瑶
-
依托单位: